Full-Time

Managing Director Italy

Deadline 9/15/26
Fresenius Medical Care

Fresenius Medical Care

11-50 employees

Operates dialysis facilities and renal care

Compensation Overview

€140k/yr

+ Short-term incentive plans + Long-term incentive plans

Milan, Metropolitan City of Milan, Italy

Hybrid

Hybrid role with on-site days at Palazzo Pignano, Lombardy, Italy.

Category
Business & Strategy
Required Skills
Sales
SAP Products
Marketing
Data Analysis

Get referred to Fresenius Medical Care

See people who can refer or advise you

Requirements
  • 8–12 years business experience (Sales, Marketing, Commercial, GM), incl. 5+ years leadership in regulated industries (MedTech/healthcare preferred)
  • Proven track record in growth, profitability, and commercial transformation
  • Strong expertise in customer management, pricing, tenders, and strategic accounts
  • Experience in matrix, international, and cross-functional environments (Italy market knowledge is a plus)
  • Solid understanding of healthcare markets, procurement, and compliance frameworks
  • Ability to lead teams, manage complexity, align stakeholders, and deliver results
  • Skilled in negotiation, communication, and driving change/innovation
  • Proficient in MS Office, CRM/SAP, data analysis
  • Italian & English fluent
  • Willing to travel, work internationally, and operate across time zones
Responsibilities
  • Lead the Care Enablement business in Italy with full responsibility for Sales, Marketing, and Customer Service, ensuring alignment with company strategy and priorities
  • Translate global and regional strategies into clear local plans, driving growth, profitability, market share, and customer satisfaction
  • Own commercial performance, including sales, margins, pricing, and budget delivery, while ensuring effective execution of go-to-market strategies, tenders, CRM adoption, and analytics
  • Define and execute business plans, targets, and customer engagement strategies, monitor KPIs, and take corrective actions to address risks and opportunities
  • Ensure strong cross-functional alignment across HR, Operations, Logistics, Finance, Procurement, Quality, and Regulatory to support business objectives and operational excellence
  • Act as the main interface with regional and global teams and resolve critical business, customer, or operational issues
  • Build and maintain relationships with key healthcare stakeholders, institutions, and decision-makers, driving a strong customer-centric approach and translating market insights into actions
  • Lead strategic accounts and major tenders, strengthening competitive positioning and promoting integrated solutions
  • Ensure high-quality customer service and a seamless end-to-end customer experience through close collaboration across functions
  • Ensure compliance with corporate policies, healthcare regulations, and local laws, while managing risks and maintaining strong governance and ethical standards
Fresenius Medical Care

Fresenius Medical Care

View

Fresenius Medical Care North America runs a network of dialysis facilities and outpatient labs to deliver coordinated kidney care for hundreds of thousands of patients. It also offers specialty pharmacy and laboratory services and manufactures a wide range of dialysis equipment, disposables, and renal drugs. The company treats patients by providing dialysis and related care at its clinics, supported by the equipment, supplies, and medicines it develops and distributes. FMCNA differentiates itself through its size and integration as the world's largest fully integrated renal company, with a nationwide network covering care delivery, drugs, labs, and manufacturing, aiming to provide high-quality, convenient access to comprehensive services across North America.

Company Size

11-50

Company Stage

Late Stage VC

Total Funding

$40.2M

Headquarters

Waltham, Massachusetts

Founded

1996

Get referred to Fresenius Medical Care

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 operating income rose 23%, showing transformation gains reached profitability.
  • FME25+ delivered EUR 67 million savings in Q2 2026 and targets EUR 1.2 billion.
  • Real-world evidence studies in July and August 2026 strengthen high-volume hemodiafiltration adoption.

What critics are saying

  • The August 2026 outlook disappointed investors after dialysis growth stalled and shares fell 10%.
  • FME25+ closed around 100 U.S. clinics in 2026, risking patient leakage to DaVita.
  • AB 290 litigation and premium-assistance rules threaten U.S. reimbursement economics and legal spend.

What makes Fresenius Medical Care unique

  • Fresenius Medical Care controls dialysis care, equipment, labs, and specialty pharmacy end-to-end.
  • Its 5008X CAREsystem reached around 100 clinics and 100,000 treatments by May 2026.
  • kinexus and TherapyWise deepen its software moat across home dialysis and kidney therapy.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Business Wire
Mar 28th, 2024
Compsych Corporation Announces 2023 Health At Work Award Winners

CHICAGO--(BUSINESS WIRE)--ComPsych® Corporation, the world’s largest provider of mental health services and GuidanceResources® for life, today announced the honorees of the 2023 Health at Work Awards. Now in its 19th year, the ComPsych Health at Work Awards recognize organizations across a variety of sizes, industries and locations who have prioritized the health and well-being of their employees by providing innovative, multi-platform programs. “We’re thrilled to honor these stellar organizations for the investment they’ve made in building cultures that value employee mental health and wellness,” said Dr. Richard A. Chaifetz, Founder, Chairman and CEO of ComPsych. “In recent years we’ve seen a rise in anxiety as well as people needing to take leaves of absence due to mental health challenges across the workforce

U.S. Securities and Exchange Commission
Feb 12th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

U.S. Securities and Exchange Commission
Feb 12th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

U.S. Securities and Exchange Commission
Dec 6th, 2023
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

Home Health Provider
Feb 17th, 2023
Improving Access & Timely Care For Vulnerable Patients Referred To Home Health Via Telehealth Physician Support

Royal Philips (NYSE: PHG AEX: PHIA), a global leader in health technology, today announced the debut of its eCareManager 4.1 enterprise telehealth software at the American Telemedicine...